Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

          - [Release No. 34-74021; File No. SR-FINRA-2014-030]

                    On June 27, 2014, the Financial Industry Regulatory Authority, Inc. (“FINRA”) filed with the Securities and Exchange Commission (“Commission”), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (“Exchange Act ” or “Act”) [1]                                          and Rule 19b-4 thereunder,[2]                                          a proposed rule change to adopt rules relating to quotation requirements for over-the-counter (“OTC”) equity securities and to delete the rules relating to the OTC Bulletin Board Service (“OTCBB”) and thus cease its operation. The proposed rule change was published for comment in the                     **Federal Register**                     on July 15, 2014.[3]                                          On August 8, 2014, FINRA consented to extending the time period for the Commission to either approve or disapprove the proposed rule change, or to institute proceedings to determine whether to approve or disapprove the proposed rule change, to October 10, 2014. The Commission received one comment letter on the proposed rule change.[4] 

                    On October 7, 2014, the Commission instituted proceedings [5]                                          to determine whether to approve or disapprove the proposed rule change under Section 19(b)(2)(B) of the Act.[6]                                          The Commission thereafter received three comment letters in response to the Order Instituting Proceedings.[7] 

                    Section 19(b)(2) of the Act [8]                                          provides that, after initiating disapproval proceedings, the Commission shall issue an order approving or disapproving the proposed rule change not later than 180 days after the date of publication of notice of the filing of the proposed rule change. The Commission may extend the period for issuing an order approving or disapproving the proposed rule change, however, by not more than 60 days if the Commission determines that a longer period is appropriate and publishes the reasons for such determination. The proposed rule change was published for comment in the                     **Federal Register**                     on July 15, 2014. January 11, 2015 is 180 days from that date, and March 12, 2015 is an additional 60 days from that date.                

                    The Commission finds it appropriate to designate a longer period within which to issue an order approving or disapproving the proposed rule change so that it has sufficient time to consider the proposed rule change and the issues raised in the comment letters that have been submitted in connection with the proposal. As the Commission noted in the Order Instituting Proceedings, the proposal raises questions as to whether FINRA's proposed rule change is consistent with the requirements of Sections 15A(b)(6),[9]                                          15A(b)(11),[10]                                          and 17B [11]                                          of the Act. Specifically, FINRA's proposal to delete the rules governing the OTCBB, and thus cease operation of the only self-regulatory organization (“SRO”) facility that collects, publishes and distributes quotations in OTC equity securities, raises questions as to whether the proposal is consistent with the requirements of the Act, particularly under circumstances where non-SRO quotation systems are experiencing operational difficulties. In such an event, reliable and accurate quotation information for OTC equity securities may not be widely available to investors through such non-SRO systems. Extending the time within which to approve or disapprove the proposed rule change will enable the Commission to more fully consider these issues and the other issues raised in the comment letters.                

                    Accordingly, the Commission, pursuant to Section 19(b)(2) of the Act,[12]                                          designates March 12, 2015, as the date by which the Commission should either approve or disapprove the proposed rule change (File No. SR-FINRA-2014-030).                

                        For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.[13] 

Brent J. Fields,

Secretary.

# Footnotes

1.                             15 U.S.C. 78s(b)(1).                    
        Back to Citation      

2.                             17 CFR 240.19b-4.                    
        Back to Citation      

3.                                                     *See*                         Securities Exchange Act Release No. 72575 (July 9, 2014), 79 FR 41339 (“Notice”).                    
        Back to Citation      

4.                                                     *See*                         Letter from Daniel Zinn, General Counsel, OTC Markets Group Inc., dated August 5, 2014 (“OTC Markets Letter”).                    
        Back to Citation      

5.                                                     *See*                         Securities Exchange Act Release No. 73313, 79 FR 61677 (October 14, 2014) (“Order Instituting Proceedings”).                    
        Back to Citation      

6.                             15 U.S.C. 78s(b)(2)(B).                    
        Back to Citation      

7.                                                     *See*                         Letter from Dr. Lee Jackson, PAHCII, dated October 8, 2014 (“PAHCII Letter”); Letter from Barry Scadden, Vice President, ATS Trade Support and Operations, Global OTC, dated October 10, 2014 (“Global OTC Letter”); and Letter from Michael R. Trocchio, Sidley Austin LLP, on behalf of OTC Markets Group Inc., dated November 4, 2014 (“Sidley Letter”).                    
        Back to Citation      

8.                             15 U.S.C. 78s(b)(2).                    
        Back to Citation      

9.                             15 U.S.C. 78*o*                        -3(b)(6).                    
        Back to Citation      

10.                             15 U.S.C. 78*o*                        -3(b)(11).                    
        Back to Citation      

11.                             15 U.S.C. 78q-2.                    
        Back to Citation      

12.                             15 U.S.C. 78s(b)(2).                    
        Back to Citation      

13.                                 17 CFR 200.30-3(a)(57).                        
        Back to Citation      

[FR Doc. 2015-00523 Filed 1-14-15; 8:45 am]

BILLING CODE 8011-01-P